In mammals, choline is a precursor for the biosynthesis of the neurotransmitter acetylcholine and the membrane phospholipids phosphatidylcholine, sphingomyelin, and plasmalogens (1) . In addition, during its oxidation, the methyl groups of choline can be salvaged and utilized in carbon-1 metabolism
(1).
Choline oxidation occurs mainly in the liver (2) and kidney (3) , where it is oxidized by FAD-linked choline dehydrogenase (EC 1.1.99.1) to betaine aldehyde, which in turn is oxidized to betaine by betaine-aldehyde dehydrogenase (EC 1.2.1.8), an NAD-linked enzyme. Betaine can act as a source of methyl groups by remethylating homocysteine to methionine via the enzyme betaine-homocysteine methyltransferase (EC 2.1.1.5) (4). This enzyme is a cytosolic enzyme (5) and is present in the liver and kidney of humans and pigs, but only in the liver * This work was supported by Alexander Porter, Grainne Porter, and Bernie Butler; the Luker-Cobbe Bursary, Trinity College (Dublin) and Girton College (Cambridge); and the Trinity Trust, Trinity College (Dublin). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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of rats (5) . Homocysteine can also be remethylated by methionine synthase (EC 2.1.1.13), also a cytosolic enzyme, which is present in all mammalian cells (4). Methionine synthase is a cobalamin-dependent enzyme, using 5-methyltetrahydrofolate as a methyl donor, and is inactivated in vivo by inhalation of nitrous oxide, which irreversibly oxidizes the cobalamin cofactor during catalysis (6).
Inhalation of nitrous oxide has been shown to produce a neurological lesion in humans (7) , monkeys (8) ) pigs (9) , and fruit bats (10) similar to that found in humans with vitamin Blz deficiency and in patients with AIDS dementia complex (11) . However, rats exposed to nitrous oxide do not develop the neurological lesion (12) . Weir et al. (9) measured levels of S-adenosylmethionine (AdoMet)' and S-adenosylhomocysteine (AdoHcy) in various tissues from pigs and rats exposed to nitrous oxide and showed markedly reduced AdoMet/ AdoHcy ratios in neural tissue of pigs compared to controls. However, near normal AdoMet/AdoHcy ratios were measured in neural tissue of rats. Many in vivo methylation reactions are controlled by the ratio of AdoMet to AdoHcy (13) ) and markedly elevated AdoHcy levels were measured in neural tissue of pigs exposed to nitrous oxide; on the other hand, AdoMet levels were comparable to those in controls (9) . The products of all AdoMet-dependent methylation reactions are AdoHcy and methylated product. AdoHcy is hydrolyzed to adenosine and homocysteine, and tissue levels of AdoHcy are dependent on the rate of removal of the product homocysteine (13) . In mammals, the main route for removal of homocysteine is by remethylation to methionine or its degradation via cystathionine to cysteine (14) . As already mentioned, homocysteine can be remethylated by two enzymes, methionine synthase and betaine-homocysteine methyltransferase. Consequently, in the presence of nitrous oxide, the latter enzyme provides the only means by which to remethylate homocysteine to methionine.
Administered betaine has been efficacious in treatment of homocystinuria in humans (15) and has delayed onset of the neurological lesion in fruit bats (16). However, betaine is not present in significant amounts in normal diets; and thus, the usual source of betaine is by oxidation of choline (17) . The site for choline oxidation to betaine is in the mitochondria. Choline dehydrogenase is situated on the inner side of the inner mitochondrial membrane (IS), whereas betaine-aldehyde dehydrogenase activity is in the mitochondrial matrix (19) . Consequently, for oxidation to occur, choline must first traverse the mitochondrial inner membrane. The knowledge
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of the mechanism of choline transport is essential to our understanding of choline oxidation and hence supply of endogenous betaine to betaine-homocysteine methyltransferase. DeRidder (20) was the first to suggest the existence of such a choline transporter. Later work by Tyler (21) and, most recently, by Brown and Brand (22) seemed to contradict this view.
In this paper, we present comprehensive evidence for the existence of a specific choline carrier in the inner membrane of rat liver mitochondria.
EXPERIMENTAL PROCEDURES
Isolation of Mitochondria-Standard methods were used for the preparation of mitochondria from rat liver (23) and rat heart (24) . Mitochondria, from both tissues, were isolated from 200-250-g female Wistar rats in an ice-cold medium containing 250 mM sucrose, 5 mM Tris, and 1 mM EGTA adjusted to pH 7.4 with HCI at 25 "C. Mitochondrial protein was assayed by the biuret method (25) against a bovine serum albumin standard.
Measurement of Mitochondrial Matrix Volume-The mitochondrial matrix volumes were determined using the following procedure. Mitochondria (3 mg of mitochondrial protein/ml) were incubated in a medium containing 120 mM KC1, 5 mM HEPES/KOH, pH 7.0, 5 mM succinate (potassium salt), 1 mM EGTA, 5 p~ rotenone, 1 p~ TPMP (bromide salt), [U-'4C]sucrose (0.1 pCi/ml), 3H20 (1.0 pCi/ ml), and nigericin (100 pmol/mg of mitochondrial protein) and stirred a t 25 "C. All incubations were performed in a single vessel from which 1 ml samples were taken at defined time intervals and placed in 1.5-ml minifuge tubes. Experiments were stopped by brief centrifugation in a benchtop centrifuge (1 min at 10,000 X g) that pelleted the mitochondria. 500 p1 of the supernatant was removed and added to 4.0 ml of scintillant in a scintillation vial. Residual supernatant was removed with a tissue. The mitochondrial pellet was resuspended in 40 pl Triton X-100 (20%, v/v), and the base of the minifuge was cut off into a scintillation vial containing 4.0 ml scintillant. The vials were counted on a Pharmacia LKB Biotechnology 1217 Rackbeta scintillation counter set up for double isotope counting with appropriate crossover and quench corrections. The matrix volume was calculated from the difference in the 3H20 space and ['4C]sucrose spaces as described by Brown and Brand (26) .
Simultaneous Measurement of Radiolabeled Choline Uptake and Mitochondrial Membrane Potential-Radiolabeled choline uptake experiments and mitochondrial membrane potential measurements were determined using the conditions described for mitochondrial volume measurements, except that ['HITPMP, iodide salt, (0.2 pCi/ ml), and [methyl-'4C]choline were present instead of radiolabeled water and sucrose. Experiments were initiated by addition of radiolabeled choline chloride, the concentration and specific activity of which are described in the figure legends. Choline uptake was measured from the accumulation ratio of [methyl-"C]choline across the mitochondrial inner membrane. Choline accumulation was measured as the [methyl-"Clcholine space minus the [U-'4C]sucrose space, the result of which was divided by the matrix space. The [U-'4C]sucrose space was determined from the matrix volume experiments, which were performed in parallel. The membrane potential was measured simultaneously with choline uptake from the distribution of the lipophilic cation ["HITPMP. The membrane potential was calculated as described by Brown and Brand (26) .
Mitochondrial Swelling in Choline Acetate-Mitochondria (3 mg of protein) were incubated in 3 ml of 120 mM choline acetate, 5 mM HEPES, 1 mM EGTA, 1 p~ TPMP bromide, 5 p M rotenone, and 1 pg of oligomycin/ml, pH 7.0, and the initial rate of absorbance was followed at 540 nm after addition of 30 pl of 500 mM succinate (choline salt). Membrane potential and matrix volume measurements were performed in a parallel experiment as described by Brown and Brand (22) .
Thin-layer Chromatography-After choline uptake was stopped, a 5-pl sample of the supernatant was removed for thin-layer chromatographic analysis. The remaining supernatant was removed, and the pellet was dried as already described. 50 pl of trichloroacetic acid (5%, w/v) was added to the pellet in the minifuge tube, mixed, and centrifuged in the benchtop centrifuge for 5 min. A 5-yl sample of the resulting supernatant was transferred to a thin-layer chromatographic plate. Thin-layer chromatography was performed on 0.25-mm silica gel plates. The running solvent was NaCl (6%, w/v)/ methanol/NH3 (lO:lO:l, v/v). RF values were determined from unlabeled standards. The approximate RF values for choline, betaine aldehyde, and betaine are 0.25, 0.4, and 0.65, respectively. Once the separation was completed, the plate was dried in air, and 1-cm2 samples of silica were scraped into scintillation vials to which 4 ml of scintillant was added. The vials were left for 24 h and mixed before counting.
Molecular Modeling-Modeling was carried using the program Macromodel (27) on an Evans & Sutherland PS390 graphics terminal with a VAX/VMS computer. The choline and quinine models were derived from crystallographic data (28) . The model of hemicholinium-15 was built using Macromodel as no crystal structure could be found. The model of quinidine was made by inverting the quinine crystal structure about its chiral center. The choline moieties in quinine, quinidine, and hemicholinium-15 were superimposed on the crystal structure of choline using Macromodel. 
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RESULTS
Accumulation of Choline by Rat Liver Mitochondria-Mitochondria were incubated in a high potassium medium in the presence of nigericin and succinate as described under "Experimental Procedures." Addition of nigericin to mitochondria suspended in a high potassium medium abolishes the pH gradient, and as a result, A* increases so that the protonmotive force equals A 9 (29). A time course of [rnethyl-14C] choline uptake by rat liver mitochondria showed that radiolabel was accumulated in the matrix at high membrane potential ( Fig. 1) . The uptake began to plateau at 15 min with an apparent maximum choline accumulation ratio of %fold, corresponding to a matrix concentration of 8 mM. Thin-layer chromatography was performed on matrix and medium samples at defined time points during the time course. Fig. 2A shows that choline, although accumulated, was also oxidized to betaine within the matrix despite the presence of 5 pM rotenone. Furthermore, radiolabeled betaine, produced as a result of choline oxidation, was detectable in the medium after 15 min, and its concentration increased linearly with time ( Fig. 2B) .
Addition of the uncoupler FCCP in the presence of nigericin a t time 0 dissipated the membrane potential completely. Under these conditions, choline uptake occurred only until equilibrium was established, i.e. -1-fold accumulation (data not shown). Addition of FCCP at 20 min, during energized uptake, caused immediate efflux of choline from the matrix (data not shown).
Choline Uptake by Rat Liver Mitochondria: Effect of Choline Concentration-Rat liver mitochondria were suspended in a range of choline acetate concentrations in the presence of rotenone. Initial swelling rates were measured as a function of choline concentration after addition of succinate. It was shown that the initial rate of swelling of mitochondria was directly proportional to the concentration of choline in the medium (Fig. 3) . Furthermore, by titration of the membrane potential (A*) with FCCP, it was confirmed that the initial The experiment was initiated by addition of 1 mM choline chloride containing [methyl-14C]choline to give a final specific activity of 80 pCi/mmol. Samples (1 ml) of incubation medium were subsequently taken at 1-, 5 -, and 5-min intervals and processed as described under "Experimental Procedures." The graph shows the accumulation of choline (0) and membrane potential (0) as a function of time. The experiment was repeated for three separate mitochondrial preparations, and each determination was made in triplicate (mean f S.E.,
swelling rate shows a non-ohmic relationship with membrane potential (Fig. 4) (22) .
Radiolabeled choline uptake was also measured as a function of choline concentration, but using much lower concentrations within the physiological range. The rate of choline uptake was measured a t high membrane potential and showed saturation kinetics (Fig. 5 ) . A K, of 220 p~ and a V, , , of 0.4 nmol/mg of protein/min were calculated for choline uptake data fitted to a rectangular hyperbola for Michaelis-Menten kinetics using the Enzfitter program (Elsevier Biosoft, Cambridge, UK). The standard errors associated with the curve fit are f 3 0 pM for the K, and f0.02 nmol/mg of protein/min for the V,,,,,. The rate of radiolabeled choline uptake was also measured as a function of membrane potential using a choline concentration of 1 mM. The rate of uptake showed a linear dependence on membrane potential, and a rate of uptake of -0.1 nmol/mg of protein/min could be measured at zero potential (Fig. 6) .
Choline Uptake across Mitochondrial Inner Membrane: Effect of Specific High Affinity Analogues-A number of high affinity inhibitors of mitochondrial choline transport were identified. These compounds are analogues of choline. Fig. 7A shows a Lineweaver-Burk plot (30) for the choline uptake process in the presence and absence of the high affinity inhibitor hemicholinium-3. Inhibition by hemicholinium-3 is competitive with a K, of 17 pM. The Ki values for the other high affinity inhibitors of choline uptake were calculated using Dixon plots (31) . The type of inhibition was determined using Cornish-Bowden plots (data not shown) (32) . Quinine is a competitive inhibitor of choline uptake with a Ki of 15 p~ (Fig. 7 B ) . Hemicholinium-15 is a competitive inhibitor with a K; of 55 p~ (Fig. 7C) , and quinidine, a stereoisomer of quinine, shows competitive inhibition with a I C i of 127 p~ (Fig. 7 0 ) . The inhibitory effects of many other compounds on choline uptake were also investigated; the results are summarized in Tables I and I1 and will be referred to under "Discussion."
Effect of Other Mitochondrial Transporter Inhibitors on Choline Uptake-To investigate whether choline is transported across the mitochondrial inner membrane on other known transport systems, choline uptake was tested in the presence of inhibitors of these transporters. The following inhibitors were investigated and were found to be without effect: 30 pM mersalyl (phosphate carrier) (33), 90 p M Nethylmaleimide (phosphate carrier) (34), 5 mM o-octanoyl-Lcarnitine chloride (carnitine carrier) (351, 500 pM a-cyano-4-hydroxycinnamate (pyruvate and carnitine carriers) (36, 37) , 2 p~ carboxyatractyloside (adenine nucleotide translocator) (38), 1.5 pM ruthenium red (calcium uniporter) (39), 120 p~ lanthanum chloride (calcium uniporter) (40) , 150 p~ p-chloromercuribenzoate (neutral amino acid carrier) (41), 10 mM butyl malonate (dicarboxylate carrier) (34), and 10 mM phenyl succinate (a-ketoglutaratelmalate exchanger) (42), but 10 mM carballylic acid (tricarboxylate carrier) (43) lowered A 0 and inhibited choline uptake rate by 30%. Choline uptake was also investigated in the presence of L-ornithine at 10 times the K, value for the ornithine carrier (44); however, choline uptake was not inhibited. Furthermore, in the presence of 10 mM L-carnitine, choline uptake was not inhibited (in contrast with Ref. 19) . N,N'-Dicyclohexylcarbodiimide (6 PM) (45) and oligomycin (1 p M ) (46) , which inhibit ATPase activity, likewise had no effect on choline transport. Finally, the rate porter and Kf uniporter processes using experimental conditions as described (47, 48). In both cases, hemicholinium-3 and hemicholinium-15 had no effect on either the K+/H+ antiporter or the K+ uniporter. Quinine, on the other hand, inhibited both these transporters to the extent reported in the literature (47, 48). It was further shown that hemicholinium-3, hemicholinium-15, and quinine had no effect on state 3 and 4 respiration rates, indicating that they had no effect on the dicarboxylate carrier or the adenine nucleotide transof choline uptake did not differ when the HEPES buffer was inhibit uptake of choline despite the similarity in their stmc-of choline dehydrogenase is negligible in rat heart, whereas tures. high activity has been reported for rat liver (2). Therefore, Quinine, however, is known to inhibit the K+/H+ antiporter mitochondrial choline transport activity by these two tissues in Me-depleted mitochondria (47), and quinine and quini-was compared. Rat heart mitochondria were incubated under dine partially inhibit the K+ uniporter (48). To investigate the same conditions used to investigate [rnethyl-14C]choline the possibility that choline is transported on these transport uptake in liver mitochondria. Rat heart mitochondria did not systems, we compared the inhibitory effects of hemicholi-accumulate choline. After a 10-min incubation, choline accunium-3, hemicholinium-15, and quinine on the K+/H+ anti-mulation in rat heart mitochondria was -4% that of rat liver locator. changed to a phosphate buffer. Therefore, HEpES did not [Quinidine) pM mitochondria at the same time point, a figure that probably represents the contribution of nonspecific uptake.
DISCUSSION
A time course of choline uptake was measured at high membrane potential. Fig. 1 shows that at high A*, in the presence of succinate and rotenone, choline is maximally accumulated &fold, equivalent to a matrix concentration of 8 mM. The time course began to plateau after 15 min, although there is no reduction in membrane potential. Similar time courses were measured when (i) rotenone was substituted with Amytal and the mitochondria were energized with succinate, (ii) rotenone plus myxothiazol were present and the mitochondria were energized with ascorbate plus TMPD, and (iii) when rotenone plus cyanide were present and the mitochondria were energized with an ATP-regenerating system. Analysis of the time course energized with succinate in the presence of rotenone, using thin-layer chromatography, showed that although choline was being transported into the matrix, it was also being metabolized to betaine (Fig. 2 A ) . In addition, betaine produced as a result of choline oxidation was detectable in the medium after 15 min, and its concentration increased linearly with time (Fig. 2B) . Therefore, it would appear that choline is being taken up continuously over the time period and that the plateau, apparently representing maximum accumulation, is in fact due to efflux of radiolabel in the form of betaine.
In the absence of A*, after the addition of the uncoupler FCCP, choline uptake occurs only until equilibrium is established, i.e. -1-fold accumulation. Addition of FCCP at 20 min, during energized uptake, caused immediate efflux of choline from the matrix, demonstrating that accumulation is an electrophoretic process.
Conflicting reports have previously appeared in the literature on the inhibitory effects of the respiratory chain inhibitor rotenone on choline oxidation in isolated mitochondria (49-52). It is clear from our results that choline is being oxidized to betaine despite the presence of rotenone. The insensitivity of choline oxidation to respiratory chain inhibitors may be explained by two observations in the literature. First, Qiu and Lin (53) showed that choline dehydrogenase can reduce atmospheric oxygen in vitro and suggested that the soluble enzyme in vivo can use oxygen as an acceptor. Second, Tsunge et al. (54) have reported that betaine aldehyde can be oxidized by choline dehydrogenase, thus providing a means by which to circumvent the betaine-aldehyde dehydrogenase NAD-dependent oxidation step. An example of such a system does exist in nature. The choline dehydrogenase enzyme of Escherichia coli can reduce atmospheric oxygen and oxidize betaine aldehyde to betaine (55), and we propose that this is also happening in our experiments.
The concentration dependence of the choline uptake system was then investigated to establish whether uptake was a saturable or nonsaturable process. Brown and Brand (22) had shown, using swelling experiments, that cations can diffuse across the mitochondrial inner membrane at high A*. Fig. 3 shows that at high A*, the swelling rate is a linear function of external choline concentration, indicating that choline diffuses across the mitochondrial inner membrane under these conditions. Furthermore, by titration of the A* with FCCP, it was confirmed that the initial swelling rate is a non-ohmic function of A* (Fig. 4) (22) .
However, radiolabeled choline uptake was also measured as Percent inhibition of choline uptake and structural formulas for a range of inhibitors of choline uptake Mitochondria (18 mg of protein) were incubated in 6 ml of standard incubation medium and under the conditions described under "Experimental Procedures." Analogues were present prior to initiation of uptake at a concentration of 10 mM. The experiment was initiated by addition of 500 p M choline chloride containing [methyl-14C]choline at a specific activity of 0.2 mCi/mmol. Values represent percent reduction in the choline uptake rate in the presence of inhibitor. The results are from two separate mitochondrial preparations; each determination was made in triplicate (average, n = 2). 
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a function of choline concentration, but using much lower within the first minute of incubation. This procedure autoconcentrations within the physiological range (60-340 PM) (2, matically corrected for the small amount of apparent uptake 21). The rate of choline uptake was measured as the difference due to binding of radiolabel. Furthermore, because the time in choline accumulated within the matrix between the first course showed linearity for the first 10 min of uptake (data and the fifth minute. It was assumed that binding occurred not shown), it was assumed that initial choline uptake rates Mitochondrial Choline Transporter dependence on A s and a low capacity high affinity saturable carrier-mediated process linearly dependent on A s . From the slope of the graph showing the choline swelling rate as a function of choline concentration (Fig. 3) , it is possible to make a rough estimate of the choline diffusion rate at high A s . At a K,,, of 220 pM, the estimated diffusion rate from the graph is 0.02 nmol/mg of protein/min, which is -10% of the total choline uptake rate at that concentration. Therefore, at physiological choline concentrations (60-340 p~) (2, 21), the carrier-mediated process is dominant.
In addition, a number of high affinity inhibitors of mitochondrial choline transport were identified. The inhibitors with the highest affinity were found to be hemicholinium-3 (K, = 17 pM) (Fig. 7 A ) , hemicholinium-15 (Ki = 55 p M ) (Fig.   7 B ) , quinine (K, = 13 p M ) (Fig. 7C) , and quinidine (Ki = 127 p M ) (Fig. 70) ; they are all competitive inhibitors of choline uptake. These inhibitors are also known to inhibit choline transport across plasma membranes (56, 57), and all have structural similarity to choline, a topic that will be discussed later.
To establish whether the choline transporter was unique or whether choline was being transported on another liver mitochondrial transport system, uptake was investigated in the presence of known mitochondrial transporter inhibitors. The results show that none of the inhibitors investigated inhibited choline transport. The three exceptions were carballylic acid, quinine, and quinidine. Carballylic acid apparently inhibited the choline uptake rate, but further investigation showed that carballylic acid decreased A\k and that the apparent inhibition could be attributed to this As decrease. Quinine, on the other hand, is known to inhibit the K+/H+ antiporter (47) , and quinine and quinidine partially inhibit the K' uniporter (48) . However, because of the insensitivity of these transporters to hemocholinium-3 and hemicholinium-15, it was concluded that the choline transport system is different than those for K' transport and K+/H+ exchange. It was also shown that hemicholinium-3 and quinine had no effect on state 3 and 4 respiration rates. In isolated mitochondria, respiring on succinate, the dicarboxylate and adenine nucleotide carriers have substantial control over state 3 respiration (58). An effect on the respiratory rates might have been expected if these compounds had inhibited the dicarboxylate carrier or the adenine nucleotide translocator.
Uptake of choline by rat heart mitochondria was also investigated. Rat heart mitochondria did not accumulate radiolabeled choline at high membrane potential. The absence of a choline transporter in heart mitochondria and its presence in liver mitochondria correlate with the tissue distribution of choline dehydrogenase in the rat (2).
The sole driving force for carrier-mediated choline uptake would appear to be the choline electrochemical gradient. The rationale for this interpretation is as follows. Choline is accumulated to 4 mM in the matrix a t high membrane potential within the first 5 min of the time course (Fig. 1) . Thus, assuming a mole for mole stoichiometry between the chemical species and choline, any putative chemical coupled to choline uptake would have to exist at 4 mM in the matrix. It is clear that uptake of choline is electrophoretic; therefore, a monovalent cation/choline antiporter or a monovalent anion/choline symporter is energetically not possible. On the other hand, an exchange of choline with a neutral organic zwitterion seems a more physiological possibility. However, the pool of neutral amino acids (59) and other putative neutral counterions within the matrix of isolated mitochondria such as carnitine (60) and citrulline (61) is <4 mM. Although no betaine pool has been measured in the matrix of isolated mitochondria, it has been shown that betaine efflux is not coupled to choline uptake (62). Other putative pathways might include cotransport of choline with other cations present in the medium such as K+. However, matrix accumulation of choline has been reported in nonionic low K+ media (20) to equivalent concentrations seen in a high K' medium (Fig. 1) . In short, the sole driving force for choline uptake a t physiological concentrations of choline would appear to be the choline electrochemical potential. The results are therefore consistent with this carrier-mediated process being a choline uniporter.
High choline dehydrogenase activities have been measured for rat liver and kidney (2, 3). If the rates of choline uptake and oxidation obtained in vitro are applicable to intact cells, then the choline transporter may have significant control over choline oxidation. However, further experimentation will be required before the contribution of the choline transporter to control of betaine supply to betaine-homocysteine methyltransferase is known.
In an endeavor to map the choline-binding site of this transporter, selected choline analogues were investigated for inhibitory effects on choline transport. Table I shows the chemical formulas and the degree of choline uptake activity in the presence of these analogues. Table I1 shows the structures and K, values of choline analogues with high affinity for the choline transporter. The percent inhibition values in Table I can be compared to Ki values in Table I1 by reference to N,N-dimethylaminopropyl chloride, which has a Ki of 660 ~L M and reduces choline uptake rate to 55%. First, the necessity of the quaternary nitrogen for binding of choline to the binding site was investigated. The degree of inhibition by N, N-dimethylethanolamine (deanol) (35%), N-methylethanolamine (O%), and ethanolamine (8%) demonstrates that sequential removal of the methyl groups from the quaternary nitrogen reduces affinity for the transporter. This conclusion is corroborated further by the observation that triethanolamine, a tertiary ammonium analogue, does not inhibit uptake, whereas tetramethylammonium (Table II) , a competitive inhibitor of choline uptake, shows a greater degree of inhibition (Ki = 459 p~; >55%) than does N,N-dimethylethanolamine.
Second, a comparison of inhibitory action of N,N-dimethylethanolamine (deanol) (35%) and N,N-diethylethanolamine (6%) suggests that substitution of the methyl groups on the tertiary nitrogen reduces affinity. Third, the products of choline oxidation show little or no inhibition of choline uptake. Choline, betaine, and betaine aldehyde all have quaternary ammonium groups. Substitution of the hydroxyl of the organic cation choline (K, = 220 PM) with a carboxyl to yield betaine, a neutral zwitterion, completely abolished affinity (0% inhibition). This abolition of affinity could be due to (i) the absence of a hydroxyl, (ii) the presence of a carboxyl, or (iii) the fact that betaine is neutral overall (at pH 7.0). However, the evidence from betaine aldehyde (13% inhibition) shows that the charge on the whole molecule plays no significant role in inhibition. The presence of a carbonyl instead of a carboxyl still results in dramatically reduced affinity. If the carbonyl or carboxyl is absent, as in tetramethylammonium, affinity is increased. If the carboxyl or carbonyl is replaced by a hydroxyl, as in choline, affinity is increased even more. The evidence suggests ( a ) that the hydroxyl is important for binding, and ( b ) that there is an unfavorable environment for carbonyls and carboxyls in the vicinity of that hydroxylbinding site. The conclusion is corroborated by the observation that L-carnitine, which possesses a quaternary nitrogen and a hydroxyl group on the carbon equivalent to that in choline, also shows poor inhibition (14%).
The analogues have also provided information about the environment in the vicinity of the hydroxyl group. The choline uptake rate was inhibited by N,N-dimethylaminobenzylamine (55%) and N,N-dimethylcyclohexylamine (55%), which suggests that a hydrophobic region is neighboring the hydroxylbinding site. Elongation of the choline skeleton in N,Ndimethylethanolamine (35%) and N,N-dimethylaminopropanol (30%) demonstrates that a short elongation of the choline moiety does not affect uptake. Substitution of the hydroxyl on dimethylaminopropanol (30%) with a chloride (55%) increases affinity.
One obvious point from our results is that the affinities of hemicholinium-3 (Ki = 17 p~) , hemicholinium-15 (Ki = 55 pM), quinine ( K , = 15 pM), and quinidine (Ki = 127 p M ) are greater than that of the substrate itself, choline (K,,, = 220 HM); and hence, these have been termed high affinity inhibitors. The structures of these compounds are given in Table  11 . It can be seen that a choline-like moiety exists within each of them and that the conformation of the choline moiety is dependent on the structure of the inhibitor. One important feature of hemicholinium is that the choline moiety is in an almost fixed conformation. Similarly, part of the choline moieties within quinine and quinidine are in a fixed conformation. It is, therefore, clear that a certain choline conformation is favored for binding to the mitochondrial choline transporter. A comparison of the affinities of quinine (K, = 15 p M ) and quinidine (Ki = 127 p~) shows that a change in the chirality changes the affinity of binding to the choline transporter by -8.5-fold. This change presumably destroys the similarity to choline's bound conformation. By use of molecular modeling, it was possible to compare conformations of choline, hemicholinium-15, quinine, and quinidine; Fig. 8 shows that the crystal structure of choline is practically superimposable upon the choline moieties within quinine and hemicholir$um-15; the root mean square deviations are 0.055 and 0.12 A, respectively. On the other hand, the choline moiety in quinidine is clearly not superimposable on those of quinine and hemicholinium-15, suggesting that the position of the hydroxyl group is important in binding. This accords with the observed binding affinities for quinine and quinidine.
There are two points on the structure of the high affinity inhibitors that require further comment. First, the observations from the inhibitor studies, using analogues of choline, suggested that substitution of the methyl groups on the nitrogen reduced their effectiveness as inhibitors. However, it is clear that the nitrogen in the quinuclidine rings of quinine and quinidine and the morpholinium rings of hemicholinium-3 and hemicholinium-15 are substituted, yet these compounds have high affinity. The fact that these substitutions occur within the constraints of the morpholinium ring (in the case of hemicholiniums) and the quinuclidine ring (in the case of quinine and quinidine) may be of significance in explaining this apparent discrepancy. Second, the preference of the choline-binding site for a quaternary nitrogen is not corroborated by the observation that quinine and quinidine have low K, values for the carrier. Both these compounds have a tertiary nitrogen in their quinuclidine ring. However, this nitrogen will be protonated at pH 7, which therefore may explain their effectiveness as inhibitors (the pK, values for the quinuclidine nitrogen in quinine and quinidine are 8.4 and 8.8, respectively). Finally, the nature of the mitochondrial choline-binding site appears to share similar characteristics with choline transporters in plasma membranes (56). Clearly, isolation and structural analysis of the choline transporter are required before the conclusions from these inhibitor studies can be confirmed.
